QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/04 Breast cancer  Multicenter study  PEG-rhG-CSF  Neutropenia   Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 BREAST CANCER RESEARCH AND TREATMENT, 2018, 卷号: 168, 期号: 2 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：55/0  |  提交时间：2019/12/05 Breast cancer  Multicenter study  PEG-rhG-CSF  Neutropenia   miR-1307-3p suppresses the chondrogenic differentiation of human adipose-derived stem cells by targeting BMPR2 期刊论文 2018, 卷号: 42, 期号: 6, 页码: 3115-3124 作者:  Yang, Zhen;  Li, Rui;  Ao, Jun;  Wa, Qing-De;  Zhang, Yi 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/05 Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study 期刊论文 Breast Cancer Research and Treatment, 2018, 卷号: 168, 期号: 2, 页码: 389-399 作者:  Xie, Jie;  Cao, Jun;  Wang, Jing-fen;  Zhang, Bai-hong;  Zeng, Xiao-hua 收藏  |  浏览/下载：13/0  |  提交时间：2019/12/27 Breast cancer  Multicenter study  Neutropenia  PEG-rhG-CSF